Crossover Health Funding: $292M Raised, Series D (2021)

Crossover Health funding overview

Crossover Health has raised $292M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series D announced in March 2021. The round record for Crossover Health runs through 2021; nothing later has been disclosed. Investors on record include Deerfield Management, Norwest Venture Partners, Avidity Partners, Foresite Capital, Irving Investors, OrbiMed and 3 others. 9 distinct backers are named across the disclosed rounds.

Crossover Health at a glance

Total raised: $292M
Latest round: Series D
Latest round date: March 2021
Notable investors: Deerfield Management, Norwest Venture Partners, Avidity Partners, Foresite Capital, Irving Investors, OrbiMed, Perceptive Advisors, PFM Health Sciences

Frequently asked about Crossover Health funding

How much has Crossover Health raised?: Crossover Health has raised $292M in total disclosed funding across the rounds on record.
Who has invested in Crossover Health?: Deerfield Management, Norwest Venture Partners, Avidity Partners, Foresite Capital, Irving Investors, OrbiMed are named among the investors backing Crossover Health.
What was the latest Crossover Health funding round?: The most recent disclosed round is a Series D, announced in March 2021.
Where is Crossover Health based?: No headquarters location is disclosed for Crossover Health.
When did Crossover Health last raise?: The last disclosed Crossover Health round closed in March 2021 at Series D.

We update the Crossover Health record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies and their backers are listed below.

Crossover Health Funding: $292M Raised, Series D (2021)

Crossover Health funding overview

Crossover Health at a glance

Frequently asked about Crossover Health funding

Companies related to Crossover Health (18)

Browse related funding lists (7)